Washington Trust Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Washington Trust Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-72	Closed	-$2.77K	–	692
2023 Q2	$2.77K	Hold	72	–	–	﹤0.01%	610
2023 Q1	$1.67K	Buy	+72	New	+$1.72K	﹤0.01%	741

Washington Trust Advisors's KDNY Position: Q3 2023 in Review

Washington Trust Advisors sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 72 shares — an estimated $2.77K sold.

Washington Trust Advisors first reported a position in KDNY in Q1 2023 and held it in 2 quarters. The position peaked at $2.77K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Washington Trust Advisors reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Washington Trust Advisors sold 72 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.77K.
Washington Trust Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Washington Trust Advisors's Chinook Therapeutics, Inc. Common Stock position peaked at $2.77K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Washington Trust Advisors's 13F filing for Q3 2023, filed 18 Oct 2023.